Witty, who is battling to repair GSK's corporate reputation, was speaking as
GSK's shares fell nearly 5% to pounds 14.81, making it the biggest faller on the
Witty said: "I remain very concerned about allegations concerning our
"In a company of our size operating in almost every country in the world there's always a small potential for some people to step outside procedure," Witty said. "This isn't acceptable, and where we are aware of misconduct, we take action including dismissal from the company." He added that the company had changed the way it did business, including "how we reward our sales representatives, and stopping payments to doctors to speak on our behalf or to attend medical congresses".
Last week GSK admitted it had dismissed staff in
SFO head David Green told Reuters the Chinese government had a clear interest in rooting out bribery and corruption, though it might have "slightly different perspectives" from the SFO. The US department of justice is also investigating GSK for possible breaches of the foreign corrupt practices act.
A British-US couple, who have been charged with illegally obtaining private information by
GSK hired Humphrey's firm ChinaWhys to investigate the "serious breach of privacy and security" relating to Reilly rather than the allegations themselves. GSK's internal investigations have not found any evidence of widespread fraud.
Despite the problems in
GSK has introduced new inhaled medicines - Breo and Anoro - to offset the decline in its biggest seller, asthma drug Advair, which still makes up nearly a fifth of sales but has come off patent. Uptake of Breo has been slow while Anoro looks more promising, Witty said.
He said GSK was in a period of transition, and stressed that it had a strong pipeline of new medicines, with six drugs approved last year and more than 40 in late-stage development. The worst of the patent losses are behind it. GSK believes Tivicay, to treat HIV, could become one of its most successful launches.
Most Popular Stories
- U.S. Families 'Extraordinarily Vulnerable': Yellen
- Hillary Clinton to Address CHCI Conference
- Larry Ellison Steps Down as Oracle CEO
- Alibaba Prices IPO at $68 a Share
- Veterans to Get Training as Solar Panel Installers
- Apple Locks Itself Out of Devices
- Hispanics Doubt Marco Rubio's Chances
- Wildfires Rage in California
- John Cantlie Delivers ISIS Message to Save Life
- Alibaba: Today China, Tomorrow the World